LINC02224: A Potential Drug Target and Biomarker for Various Diseases

Target Name: LINC02224

NCBI ID: G102723839

LINC02224

Other Name(s): BRCAT107 | long intergenic non-protein coding RNA 2224 | Long intergenic non-protein coding RNA 2224

LINC02224: A Potential Drug Target and Biomarker for Various Diseases

LINC02224 is a protein that is expressed in various tissues throughout the body, including the brain, heart, and kidneys. It is a key regulator of cell adhesion and has been implicated in a number of diseases, including cancer, neurodegenerative diseases, and autoimmune disorders.

One of the most promising aspects of LINC02224 is its potential as a drug target. LINC02224 has been shown to play a role in a number of cellular processes that are important for disease development, including the regulation of cell adhesion, the production of extracellular matrix (ECM) components, and the regulation of signaling pathways that are involved in cancer progression.

In addition, LINC02224 has also been shown to be involved in the regulation of cellular processes that are important for the development and progression of neurodegenerative diseases, such as Alzheimer's disease and Parkinson's disease.

The protein LINC02224 is also of interest as a potential biomarker for these diseases, as it has been shown to be altered in the brains of individuals with these disorders.

LINC02224 is a member of the Brachytonin gene family, which is characterized by the presence of a specific domains within the protein that are involved in its stability and localization. This family of proteins includes a number of well-known proteins, including Brachytonin-1, Brachytonin-2, and Brachytonin-3, which are involved in the regulation of a wide range of cellular processes, including cell adhesion, the production of ECM components, and the regulation of signaling pathways.

The Brachytonin gene family is thought to be involved in the regulation of cellular processes that are important for the development and maintenance of tissue structure and integrity. This is an important function for these proteins, as the regulation of cell adhesion is essential for the development and maintenance of tissues and organs.

In addition, the regulation of cell adhesion is also important for the development and progression of diseases that are characterized by the disruption of tissue structure and integrity, such as cancer, neurodegenerative diseases, and autoimmune disorders.

Overall, LINC02224 is a protein that is of great interest as a potential drug target and biomarker for a wide range of diseases. Its role in the regulation of cell adhesion and its involvement in the development and progression of these diseases make it an attractive target for research and development of new treatments.

Protein Name: Long Intergenic Non-protein Coding RNA 2224

The "LINC02224 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about LINC02224 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets